Director, Stakeholder Engagement Strategy

Mallinckrodt Pharmaceuticals•Bridgewater, NJ

1d•$199,000 - $236,000•Onsite

About The Position

The Director, Stakeholder Engagement Strategy is a commercial strategy role responsible for defining and governing external stakeholder engagement across the portfolio. The role focuses on advisory boards, KOL strategy, scientific engagement, and organized networks across multiple therapeutic areas. This position ensures coordinated, purposeful, and non-duplicative engagement with KOLs to advance brand objectives. This role will report into the Executive Director, Brand Strategy (Brand Lead).

Requirements

Strong strategic thinking, stakeholder influence, portfolio-level decision making, and the ability to operate across multiple therapeutic areas.
Deep understanding of KOL ecosystems and healthcare networks is required.
Understanding of engagement operations, compliance, and field constraints
Strong cross functional collaboration: Partner with Marketing, Operations and field teams to ensure coordinated stakeholder engagement and clear execution intent.
10+ years in pharma/biotech with experience in HCP marketing, stakeholder strategy, or medical-commercial interface.
Multi-TA experience preferred with strong cross-functional influence skills.
Experience with Rheumatology and/or Ophthalmology strongly preferred
Experience working with networks/supergroups

Responsibilities

Define approach for engaging organized networks, supergroups, and centers of excellence. Establish guidelines, measurement plans
Define stakeholder strategy across therapeutic areas. Establish frameworks for stakeholder prioritization, engagement intent, and channel selection while ensuring consistency and efficient resource allocation.
Own the design, cadence, and governance of advisory boards across the portfolio. Ensure clear objectives, eliminate duplication, and optimize stakeholder engagement frequency.
Develop and maintain KOL strategies by TA, defining roles and engagement models aligned to lifecycle stage and brand strategic objectives for each TA.
Define speaker bureau strategy including optimal speaker count, allocation across therapeutic areas, and utilization strategy informed by engagement analytics to maximize impact and efficiency.